Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2002-3-28
pubmed:abstractText
To assess the effect of mealtime amylin replacement with pramlintide on long-term glycemic and weight control in patients with type 1 diabetes.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0149-5992
pubmed:author
pubmed:issnType
Print
pubmed:volume
25
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
724-30
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:11919132-Adolescent, pubmed-meshheading:11919132-Adult, pubmed-meshheading:11919132-Aged, pubmed-meshheading:11919132-Amyloid, pubmed-meshheading:11919132-Body Weight, pubmed-meshheading:11919132-Diabetes Mellitus, Type 1, pubmed-meshheading:11919132-Dose-Response Relationship, Drug, pubmed-meshheading:11919132-Double-Blind Method, pubmed-meshheading:11919132-Drug Therapy, Combination, pubmed-meshheading:11919132-Female, pubmed-meshheading:11919132-Hemoglobin A, Glycosylated, pubmed-meshheading:11919132-Humans, pubmed-meshheading:11919132-Hypoglycemia, pubmed-meshheading:11919132-Hypoglycemic Agents, pubmed-meshheading:11919132-Incidence, pubmed-meshheading:11919132-Insulin, pubmed-meshheading:11919132-Islet Amyloid Polypeptide, pubmed-meshheading:11919132-Male, pubmed-meshheading:11919132-Middle Aged, pubmed-meshheading:11919132-Patient Compliance, pubmed-meshheading:11919132-Placebos
pubmed:year
2002
pubmed:articleTitle
A randomized study and open-label extension evaluating the long-term efficacy of pramlintide as an adjunct to insulin therapy in type 1 diabetes.
pubmed:affiliation
Henry Ford Hospital, Detroit, Michigan, USA.
pubmed:publicationType
Journal Article, Clinical Trial, Comparative Study, Randomized Controlled Trial, Multicenter Study